Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTINUCLEAR ANTIBODY (ANA) - ANVISA Registration 82532910013

Access comprehensive regulatory information for ANTINUCLEAR ANTIBODY (ANA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82532910013 and manufactured by DIA PRO DIAGNOSTIC BIOPROBES S.R.L.. The registration is held by AUREUM COMERCIO DE PRODUTOS MEDICOS E DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including INOVA DIAGNOSTICS, INC., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
82532910013
Registration Details
ANVISA Registration Number: 82532910013
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

DIA.CHEMILUX IgG anti-SCL70
Risk Class II

Registration Details

82532910013

25351612692202206

45682834000162

Company Information

Italy
PT: ITÁLIA

Dates and Status

Jan 02, 2023

VIGENTE

09/18/2025 19:00:01